LAZCLUZE

Film-coated tablet, 240mg
RxActive license

Active substance (INN)

lazertinib

Pharmaceutical form

Pharmaceutical formFilm-coated tablet
Strength240mg
PackagingUkupno 28 film tableta u blisteru (2x14) u kartonskoj kutiji
ManufacturerJanssen Cilag S.p.A., Italy
Therapeutic groupAntineoplastic and immunomodulating agents (L01EB09)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateSeptember 12, 2025

Analogs in Montenegro

1

Other medicines with the same active substance

LAZCLUZERx
Film-coated tablet, 80mgJanssen Cilag S.p.A.
Source: CInMED register